These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 19033530)
1. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Sweetser S; Busciglio IA; Camilleri M; Bharucha AE; Szarka LA; Papathanasopoulos A; Burton DD; Eckert DJ; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G295-301. PubMed ID: 19033530 [TBL] [Abstract][Full Text] [Related]
2. Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G377-84. PubMed ID: 21596994 [TBL] [Abstract][Full Text] [Related]
3. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730 [TBL] [Abstract][Full Text] [Related]
4. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Esfandyari T; Camilleri M; Busciglio I; Burton D; Baxter K; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G137-45. PubMed ID: 17395895 [TBL] [Abstract][Full Text] [Related]
5. Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome. Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR Dig Liver Dis; 2014 Feb; 46(2):113-8. PubMed ID: 24095618 [TBL] [Abstract][Full Text] [Related]
6. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Delgado-Aros S; Chial HJ; Camilleri M; Szarka LA; Weber FT; Jacob J; Ferber I; McKinzie S; Burton DD; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G558-66. PubMed ID: 12631557 [TBL] [Abstract][Full Text] [Related]
7. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Viramontes BE; Malcolm A; Camilleri M; Szarka LA; McKinzie S; Burton DD; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1468-76. PubMed ID: 11705752 [TBL] [Abstract][Full Text] [Related]
8. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Odunsi ST; Camilleri M; Bharucha AE; Papathanasopoulos A; Busciglio I; Burton D; Zinsmeister AR Dig Dis Sci; 2010 Mar; 55(3):709-15. PubMed ID: 19291400 [TBL] [Abstract][Full Text] [Related]
9. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656 [TBL] [Abstract][Full Text] [Related]
11. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Acosta A; Camilleri M; Busciglio I; Boldingh A; Nelson AD; Burton D Dig Dis Sci; 2016 Mar; 61(3):852-60. PubMed ID: 26467700 [TBL] [Abstract][Full Text] [Related]
12. Adrenergic modulation of human colonic motor and sensory function. Bharucha AE; Camilleri M; Zinsmeister AR; Hanson RB Am J Physiol; 1997 Nov; 273(5):G997-1006. PubMed ID: 9374695 [TBL] [Abstract][Full Text] [Related]
13. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Johanson JF; Ueno R Aliment Pharmacol Ther; 2007 Jun; 25(11):1351-61. PubMed ID: 17509103 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Wong BS; Camilleri M; Busciglio I; Carlson P; Szarka LA; Burton D; Zinsmeister AR Gastroenterology; 2011 Nov; 141(5):1638-47.e1-7. PubMed ID: 21803011 [TBL] [Abstract][Full Text] [Related]
15. High body mass alters colonic sensory-motor function and transit in humans. Delgado-Aros S; Camilleri M; Garcia MA; Burton D; Busciglio I Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G382-8. PubMed ID: 18617555 [TBL] [Abstract][Full Text] [Related]
16. Lubiprostone neither decreases gastric and small-bowel transit time nor improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled study. Hooks SB; Rutland TJ; Di Palma JA Gastrointest Endosc; 2009 Nov; 70(5):942-6. PubMed ID: 19577749 [TBL] [Abstract][Full Text] [Related]